Only one of the two prior Topamax cases to be decided by the Superior Court was presented to the state’s Supreme Court for a potential appeal. Read more
The Pennsylvania Superior Court last month upheld an $11 million verdict returned against a Johnson & Johnson unit on behalf of a boy who was born with a cleft palate and other defects a... Read more
A Pennsylvania judge has denied a motion for a new trial filed by Janssen Pharmaceuticals Inc. in a suit involving a child’s birth defects. The jury had awarded $11 million to the parents on... Read more
Janssen Pharmaceuticals, Inc., a Johnson & Johnson (J&J) unit, has agreed to settle with plaintiffs in 76 suits pending in Pennsylvania court over alleged birth defects in the babies... Read more
A Pennsylvania jury has returned a $3 million verdict against a Johnson & Johnson unit in a case accusing the company of failing to warn a woman of the risk of birth defects when using i... Read more
A Philadelphia state jury returned a verdict against Janssen Pharmaceuticals Inc. in a Topamax lawsuit last month. The company will have to pay more than $10 million to the parents of a chil... Read more
Johnson & Johnson’s Janssen Pharmaceutical unit must pay $4.02 million in a lawsuit claiming that its seizure drug Topamax caused birth defects. The Philadelphia state court jury deliber... Read more
On May 4, 2011, the Food and Drug Administration notified the medical community and the public that there is an increased risk for the development of oral cleft (cleft lip and/or cleft palat... Read more
The U.S. Department of Justice has reached two settlements with pharmaceutical companies that will call for a total of more than $100 million in penalties under the False Claims Act and the... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.